Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Jul. 05 | Belgian finance regulator issues warning about Hyloris Pharmaceuticals | RE |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Business Summary
Number of employees: 42
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -4.68% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Belgium
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -4.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jacobsen
FOU | Founder | 50 | 11-12-31 |
Stijn van Rompay
FOU | Founder | 48 | 11-12-31 |
Director of Finance/CFO | 53 | 21-09-22 | |
Dietmar Aichhorn
COO | Chief Operating Officer | - | 20-09-30 |
Sven Watthy
IRC | Investor Relations Contact | - | - |
General Counsel | 63 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carolyn Myers
BRD | Director/Board Member | 66 | 19-12-31 |
James Gale
BRD | Director/Board Member | 74 | 19-12-31 |
Leon van Rompay
BRD | Director/Board Member | 75 | 19-12-31 |
Chris Buyse
BRD | Director/Board Member | 59 | - |
Stijn van Rompay
FOU | Founder | 48 | 11-12-31 |
Stefan Yee
CHM | Chairman | 62 | 19-09-30 |
Marc Foidart
BRD | Director/Board Member | - | 19-12-31 |
Thomas Jacobsen
FOU | Founder | 50 | 11-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,000,374 | 12,146,562 ( 43.38 %) | 0 | 43.38 % |
Company contact information
Hyloris Pharmaceuticals SA
Boulevard Patience et Beaujonc N°3/1
4000, Liege
+32 4 346 02 07
http://www.hyloris.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 354M | |
+56.89% | 809B | |
+39.52% | 624B | |
-6.55% | 351B | |
+7.92% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 166B | |
-2.57% | 157B |
- Stock Market
- Equities
- HYL Stock
- Company Hyloris Pharmaceuticals SA